SCHEMBL17701930

SCHEMBL17701930

CC[C@H]1OC(C)[C@H](OC)[C@@H](OC)[C@@H]1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24051562 0.93 SPHK1 (0.31) —
SCHEMBL12746263 0.93 SPHK1 (0.31) —
SCHEMBL13218872 0.87 SPHK1 (0.30) —
SCHEMBL13218874 0.87 SPHK1 (0.30) —
SCHEMBL15747237 0.81 — —
SCHEMBL17035801 0.81 FGF1 (0.35) —
SCHEMBL11997774 0.78 FGF1 (0.36) —
SCHEMBL9908979 0.78 SPHK1 (0.30) —
SCHEMBL25505092 0.78 FGF1 (0.36) —
SCHEMBL13159271 0.78 SPHK1 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160115542-A1 BIOMARKER OF Nrf2 ACTIVATION MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2016-04-28 — — US disclosed
Send feedback